English
-
-
Beyond COVID-19 Dengue Situation in Indonesia
ADVA16 minutes -
Dengue Virus Transmission During COVID 19 Pandemic
ADVA24 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue incidence rates in travelers
Takeda2 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Dengue serotypes
Takeda4 minutes -
Imported dengue cases in Europe
Takeda2 minutes -
Dengue: a global threat
WSPID38 minutes -
Dengue in Latam - Understand Disease Control and the Value of Vaccination
Takeda8 minutes -
Dengue in APAC - Understand Disease Control and the Value of Vaccination
Takeda13 minutes -
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia
ADVA25 minutes -
What Happens When Someone Gets Dengue Fever?
Seeker8 minutes -
Sophie Yacoub: Dengue in Vietnam
Tropical Medicine Oxford4 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021